EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer

Sangita Bhattacharyya, Hindole Ghosh, Obdulia Covarrubias-Zambrano, Krishan Jain iD, K Venkateswara Swamy, Anup Kasi, Ameer Hamza iD, Shrikant Anant iD, Michael VanSaun, Scott J Weir iD, Stefan H Bossmann, Subhash B Padhye und 1 weitere

International Journal of Molecular Sciences · 28.03.2023 · 24 (7) · 6336

DOI: 10.3390/ijms24076336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2023. Verfasst von Sangita Bhattacharyya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66103, USA. Hauptthemen laut MEDLINE: Curcumin, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Gastroenterological Association, NCI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the primary reason for cancer-related deaths in the US. Genetic mutations, drug resistance, the involvement of multiple signaling pathways, cancer stem cells (CSCs), and desmoplastic stroma, which hinders drug penetrance, contribute to poor chemotherapeutic efficacy. Hence, there is a need to identify novel drugs with improved delivery to improve treatment outcomes. Curcumin is one such compound that can inhibit multiple signaling pathways and CSCs. However, curcumin’s clinical applicability for treating PDAC is limited because of its poor solubility in water and metabolic instability. Hence, we developed a difluorinated curcumin (CDF) analog that accumulates selectively in the pancreas and inhibits PDAC growth in vitro and in vivo. In the present work, we developed its 2-hydroxy-propyl-β-cyclodextrin (HCD) inclusion complex to increase its water solubility and hydrolytic stability. The CDFHCD inclusion complex was characterized by spectroscopic, thermal, and microscopic techniques. The inclusion complex exhibited increased aqueous solubility, hydrolytic stability, and antiproliferative activity compared to parent CDF. Moreover, CDF and CDFHCD inhibited colony and spheroid formation, and induced cell cycle and apoptosis in PDAC cell lines. Hence, CDFHCD self-assembly is an efficient approach to increase water solubility and anticancer therapeutic efficacy, which now warrants advancement towards a clinical proof of concept in PDAC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminPancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumans2-Hydroxypropyl-beta-cyclodextrinSolubilityWater

Stichwörter der Autor:innen

2-hydroxypropyl-β-cyclodextrinCDFPDACcurcumincyclodextrindifluorinated curcuminpancreatic cancer

Substanzen

Curcumin2-Hydroxypropyl-beta-cyclodextrinWater

Autor:innen und Institutionen

  • Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66103, USA.
  • MIT School of Bioengineering, Sciences & Research, MIT Art, Design and Technology University, Pune 412201, India.
  • Division of Medical Oncology, University of Kansas, Kansas City, KS 66160, USA.
  • Pathology and Laboratory Medicine, University of Kansas, Kansas City, KS 66160, USA.
  • Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Interdisciplinary Science & Technology Research Academy (ISTRA), Azam Campus, University of Pune, Pune 411001, India.

ORCID-Profile: Krishan Jain, Ameer Hamza, Shrikant Anant, Scott J Weir, Prasad Dandawate

Förderung

  • American Gastroenterological Association
  • NCI NIH HHS
  • NCRR NIH HHS
  • United States Department of Defense
  • The University of Kansas Cancer Center
  • Council of Scientific and Industrial Research
  • Department of Defense
  • American Gastroenterological Association Research Scholar Award

Zitieren

APA

Bhattacharyya, S., Ghosh, H., Covarrubias-Zambrano, O., Jain, K., Swamy, K. V., Kasi, A., Hamza, A., Anant, S., VanSaun, M., Weir, S. J., Bossmann, S. H., Padhye, S. B., & Dandawate, P. (2023). Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. International Journal of Molecular Sciences, 24(7), 6336. https://doi.org/10.3390/ijms24076336

Vancouver

Bhattacharyya S, Ghosh H, Covarrubias-Zambrano O, Jain K, Swamy KV, Kasi A, et al. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. International Journal of Molecular Sciences. 2023;24(7):6336. doi:10.3390/ijms24076336

BibTeX
@article{Bhattacharyya2023,
  author = {Bhattacharyya, Sangita and Ghosh, Hindole and Covarrubias-Zambrano, Obdulia and Jain, Krishan and Swamy, K Venkateswara and Kasi, Anup and Hamza, Ameer and Anant, Shrikant and VanSaun, Michael and Weir, Scott J and Bossmann, Stefan H and Padhye, Subhash B and Dandawate, Prasad},
  title = {Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6336},
  doi = {10.3390/ijms24076336}
}
Kostenlos starten →